U.S. Wireless Telecom Stock News

NYSE:MOS
NYSE:MOSChemicals

Mosaic (MOS) Is Up 11.4% After Rare Earths Pivot And Dividend Update - Has The Bull Case Changed?

The Mosaic Company recently announced a quarterly dividend of US$0.2200 per share payable on June 2, 2026, while also advancing plans with Rainbow Rare Earths Ltd. to develop the Uberaba rare earths project in Brazil through new processing facilities targeting production by 2030. This move signals Mosaic’s effort to extract more value from its existing phosphate operations by recovering rare earth elements, potentially diversifying revenue beyond traditional fertilizers. Next, we’ll examine...
NasdaqGS:WOOF
NasdaqGS:WOOFSpecialty Retail

Is It Time To Reconsider Petco Health and Wellness Company (WOOF) After The Recent Share Price Surge

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor Lawsuits - What's Changed

In late 2025, Corcept Therapeutics received a Complete Response Letter from the FDA rejecting its New Drug Application for relacorilant on the grounds of insufficient evidence of effectiveness, prompting multiple securities class action lawsuits alleging the company misrepresented the drug’s regulatory prospects and prior FDA feedback. These lawsuits focus not just on the setback for relacorilant, but on claims that Corcept withheld repeated FDA concerns while continuing to promote the drug...
NYSE:ORI
NYSE:ORIInsurance

Old Republic Leadership Shift And Valuation Gap As Wordekemper Takes Helm

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Karooooo (NasdaqCM:KARO) Valuation Check As Cartrack Crosses Two Million Subscriber Milestone

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...
NYSE:WEX
NYSE:WEXDiversified Financial

Is WEX (WEX) Offering Value After Recent Share Price Volatility And Mixed Valuation Signals

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...
NYSE:F
NYSE:FAuto

NTSB BlueCruise Hearing Puts Ford Safety And ADAS Ambitions Under Review

The National Transportation Safety Board plans to hold a hearing on Ford Motor's BlueCruise hands free driving system following two fatal crashes. The hearing will examine how the advanced driver assistance system was used in the incidents and whether additional safety measures are needed. The review puts Ford's automated driving technology and safety practices under closer regulatory and public scrutiny. For investors watching NYSE:F at a current share price of $11.67, this hearing comes...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

Assessing LKQ (LKQ) Valuation After A Sharp Share Price And One Year Total Return Decline

LKQ stock performance context LKQ (LKQ) shares closed at $29.34, with the stock showing a 1 day return of 1.38% and a 7 day decline of 6.77%. This sets the stage for a closer look at its recent performance. See our latest analysis for LKQ. At the current share price of $29.34, LKQ’s 30 day share price return of a 13.96% decline sits alongside a 1 year total shareholder return of a 26.95% decline, pointing to fading momentum rather than a short term blip. If LKQ’s recent pullback has you...
NYSE:T
NYSE:TTelecom

Should AT&T’s US$250 Billion AI-Era Network Build-Out Plan Require Action From AT&T (T) Investors?

Earlier this month, AT&T announced over US$250.00 billion of planned U.S. connectivity investment through 2030, launched more flexible Unlimited Your Way wireless plans, and issued long-dated Canadian dollar bonds to support its network build-out. Together, these moves highlight AT&T’s push to reposition itself as a core connectivity platform for AI-era data demand while sharpening its consumer value proposition. Now we’ll examine how AT&T’s US$250.00 billion connectivity build-out plan...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Assessing Celldex Therapeutics (CLDX) Valuation After Recent Share Price Momentum

Why Celldex Therapeutics (CLDX) is on investors’ radar today Celldex Therapeutics (CLDX) has drawn attention after recent trading, with shares last closing at $29.51 and showing mixed returns over the past week, month, past 3 months, and year. See our latest analysis for Celldex Therapeutics. Recent trading has been choppy, with a 30 day share price return of 28.30% and a 1 year total shareholder return of 44.52%, set against a weaker 3 year total shareholder return of 29.47% and a 5 year...
NYSE:TTAM
NYSE:TTAMBasic Materials

A Look At Titan America (TTAM) Valuation After Recent Share Price Pullback

Recent share performance and business snapshot Titan America (TTAM) has drawn attention after a one month return showing a 16.1% decline, extending a past 3 months slide of 7.8%. This has prompted investors to reassess the cement and building materials producer. The Brussels based company reports annual revenue of US$1.65b and net income of US$178.46m, with recent revenue growth of 6.3% and net income growth of 13.7%. This has put a spotlight on how earnings support the current share...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

G-III Apparel Group (GIII) Is Down 10.4% After Weak Q4, Softer Outlook And Brand Shift - What's Changed

G-III Apparel Group has reported a weaker fourth quarter for fiscal 2026, with sales falling to US$771.49 million and a net loss of US$31.94 million, while also guiding to lower near-term revenue and earnings as it exits Calvin Klein and Tommy Hilfiger licenses and absorbs charges related to the Saks Global bankruptcy. Alongside these softer results, the company reaffirmed its portfolio shift toward higher-margin owned brands, announced a US$0.10 quarterly dividend, and outlined a US$25...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

A Look At PENN Entertainment (PENN) Valuation After Columbus Hotel And High Limit Gaming Expansion News

PENN Entertainment (PENN) is back on investors’ radar after announcing a 203-room hotel tower and an expanded high-limit table games room at Hollywood Casino Columbus, both pending regulatory approvals. See our latest analysis for PENN Entertainment. Despite the hotel and high limit room expansion plans and the recent earnings surprise in Q4 2025, sentiment around PENN has been mixed. A 21.68% 1 month share price return contrasts with a 16.27% 1 year total shareholder return decline and an...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

A Look At IDEAYA Biosciences (IDYA) Valuation After IDE892 Trial Enrollment And Pipeline Refocus

IDEAYA Biosciences (IDYA) enrolled the first patient in its Phase 1 IDE892 trial for MTAP-deleted solid tumors and updated investors on its broader MTAP-deletion and CDKN2A-deficiency pipeline. The company also trimmed certain combination studies. See our latest analysis for IDEAYA Biosciences. The latest IDE892 trial update comes after a 1-month share price return of 9.32% and a 1-year total shareholder return of 78.09%, suggesting recent momentum on top of already strong longer term...
NYSE:JLL
NYSE:JLLReal Estate

Will JLL's Accelerate 2030 Plan and US$4.4 Billion Buyback Change Jones Lang LaSalle's (JLL) Narrative

Earlier this month, Jones Lang LaSalle unveiled its Accelerate 2030 plan, pairing new long-term financial targets with an enlarged share repurchase authorization of US$4.40 billion, including a US$200 million accelerated buyback. This combination of technology-led growth ambitions and a very large capital return commitment marks a meaningful shift in how JLL is positioning itself for clients and shareholders through 2030. Next, we’ll consider how JLL’s significantly expanded share buyback...
NYSE:USPH
NYSE:USPHHealthcare

A Look At U.S. Physical Therapy’s Valuation As Shares Pull Back And P/E Stands At 53.9x

Setting the scene on U.S. Physical Therapy With no fresh headline event driving U.S. Physical Therapy (USPH) today, investors are left weighing a share price of $76.83 alongside recent return figures and the company’s latest reported revenue and net income. See our latest analysis for U.S. Physical Therapy. The recent share price pullback, including a 1-day share price return of 1.35% decline and a 30-day share price return of 11.63% decline, sits alongside a 1-year total shareholder return...
NasdaqGS:AAON
NasdaqGS:AAONBuilding

AAON (AAON) Is Down 5.0% After Mixed Q4 Results And DOE HVAC Challenge Spotlight - What's Changed

In early March 2026, AAON reported fourth-quarter 2025 results showing US$424.22 million in sales and full-year earnings per share of US$1.29, while also affirming a regular quarterly dividend of US$0.10 per share payable on March 30, 2026. At the same time, AAON highlighted its Alpha Class EXTREME SERIES rooftop unit’s success in the U.S. Department of Energy’s HVAC Technology Challenge, underlining how advanced dual-fuel heat pump capability and cold-weather performance could reinforce...
NasdaqGS:WIX
NasdaqGS:WIXIT

Why Wix (WIX) Is Down 6.2% After 2025 Results, 2026 Outlook And New Private Placement - And What's Next

Wix.com Ltd. recently reported its fourth-quarter 2025 results, showing revenue of US$524.27 million and a net loss of US$40.23 million, alongside full-year 2025 revenue of US$1.99 billion and net income of US$50.65 million. On the same day, Wix.com issued mid-teens percentage revenue growth guidance for both the first quarter and full year 2026 and secured a US$250,000,000 private placement featuring warrants and lock-up agreements with Durable Capital Partners and other investors,...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Praxis Precision Medicines (PRAX) Is Down 5.4% After Major Institutional Buying and FDA Filings - Has The Bull Case Changed?

In recent months, Driehaus Capital Management and Deerfield Management Company have sharply increased their holdings in Praxis Precision Medicines, adding hundreds of thousands of shares and committing a combined investment of more than US$346.79 million as the company filed two FDA new drug applications for ulixacaltamide and relutrigine. This combination of larger institutional ownership, advancing late‑stage neuroscience candidates and a cash position supported by roughly US$1.55 billion...
NYSE:FHI
NYSE:FHICapital Markets

Did Fresh Lipper Honors and Conference Spotlight Just Shift Federated Hermes' (FHI) Investment Narrative?

Earlier in March, Federated Hermes announced that four of its investment strategies received LSEG Lipper Fund Awards 2026 US for consistently strong risk‑adjusted performance, while CEO J. Christopher Donahue is scheduled to present at the RBC Capital Markets Global Financial Institutions Conference 2026 in New York on March 11. This combination of third‑party recognition and high recent earnings growth and return on equity is sharpening attention on how effectively Federated Hermes converts...
NYSE:CLVT
NYSE:CLVTProfessional Services

Is Clarivate (CLVT) Using Claude Integration to Deepen Its Data Moat or Just Follow Hype?

In early March 2026, Clarivate Plc announced it had integrated its Cortellis Regulatory Intelligence data with Anthropic’s Claude via the open Model Context Protocol, giving biopharma, biotech, medtech and clinical research organizations context-aware access to authoritative regulatory data directly within their existing AI workflows. This move highlights how Clarivate is aiming to embed its validated regulatory content deeper into customers’ day-to-day decision processes, potentially...
NasdaqGS:SVCO
NasdaqGS:SVCOSoftware

Is Silvaco Group’s (SVCO) New MIPI IP Rollout Enough To Reframe Its Loss-Making Profile?

In March 2026, Silvaco Group, Inc. completed a follow-on at-the-market US$15 million common stock offering and reported full-year 2025 revenue of US$63.06 million with a net loss of US$41.21 million, alongside guidance for first-quarter 2026 revenue of US$15 million to US$19 million. A few days earlier, the company also announced the immediate availability of Mixel MIPI Production Ready Offerings, broadening its silicon-proven mixed-signal interface IP portfolio across advanced process nodes...
NasdaqGS:STX
NasdaqGS:STXTech

Assessing Seagate Technology Holdings (STX) Valuation After Mozaic 4+ HAMR Rollout And AI Storage Demand Surge

Seagate Technology Holdings (STX) is back in focus after its Mozaic 4+ heat assisted magnetic recording platform moved from announcement to volume production with two hyperscale cloud providers, directly tied to AI driven storage demand. See our latest analysis for Seagate Technology Holdings. The latest Mozaic 4+ deployment arrives after a sharp run in Seagate’s share price, with a 90 day share price return of 34.36% and a year to date share price return of 33.45%, even after a 30 day share...
NYSE:HSY
NYSE:HSYFood

Assessing Hershey (HSY) Valuation After Strong Q4 Results And Zacks Rank Upgrade

Hershey (HSY) is back in focus after an upgrade to Zacks Rank #1, following strong Q4 results and ambitious 2026 forecasts that sit alongside fresh launches like Dot's Original Snack Mix and new Twizzlers Straws. See our latest analysis for Hershey. At a share price of $217.09, Hershey has a 90 day share price return of 15.41% and a 1 year total shareholder return of 31.45%. This suggests momentum has picked up recently, even after a softer 7 day share price return of 3.51% and ongoing cost...